Clinical Trial Update: A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of AZD5423 in healthy subjects and mild asthmatics, evaluating administration methods. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD5423

Snippet

Sponsor: AstraZeneca | Conditions: Healthy, Asthma | Phase 1 | Status: COMPLETED